ArticleBritish journal of cancer2020

Targeted therapy for mTORC1-driven tumours through HDAC inhibition by exploiting innate vulnerability of mTORC1 hyper-activation.

Fuchun Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.